- Country: Saudi Arabia
- Summary: Jd-Tu-Trace Solution Non-Radioactive to Detect the Sentinel Lymph Node in Breast Cancer with 60M Particle Dimension and Made of Iron Oxide can be Injected up to 30 Days before Operation
- SAT Ref No: 115139616
- Deadline: 26 Feb 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: JR688021
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- JD-TU-TRACE SOLUTION NON-RADIOACTIVE TO DETECT THE SENTINEL LYMPH NODE IN BREAST CANCER WITH 60M PARTICLE DIMENSION AND MADE OF IRON OXIDE CAN BE INJECTED UP TO 30 DAYS BEFORE OPERATION
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINJd-Tu-Trace Solution Non-Radioactive to Detect the Sentinel Lymph Node in Breast Cancer with 60M Particle Dimension and Made of Iron Oxide can be Injected up to 30 Days before Operation - Saudiarabia Tender
The HEALTH AFFAIRS AT THE MINISTRY OF NATIONAL GUARD, a Government sector organization in Saudi Arabia, has announced a new tender for Jd-Tu-Trace Solution Non-Radioactive to Detect the Sentinel Lymph Node in Breast Cancer with 60M Particle Dimension and Made of Iron Oxide can be Injected up to 30 Days before Operation. This tender is published on SaudiarabiaTenders under SAT Ref No: 115139616 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-02-26.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
